Results 281 to 290 of about 1,273,562 (309)

Investigator balkanization

Annals of Neurology, 2008
S Claiborne, Johnston, Stephen L, Hauser
openaire   +2 more sources

Investigating the Investigators

2016
openaire   +1 more source

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Journal of the American Academy of Dermatology, 2020
Robert Bissonnette, E Guttman-Yassky, Brett A King   +2 more
exaly  

Investigating thrombocytosis

BMJ, 2019
Abhinav, Mathur, Shehan, Samaranayake, Neill Pf, Storrar, Mark A, Vickers   +3 more
openaire   +2 more sources

Investigator (Principal Investigator)

2004
openaire   +1 more source

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

Lancet Oncology, The, 2016
Marek Trneny, Thierry Lamy, Jan A Walewski   +2 more
exaly  

Investigators' response

The Lancet Oncology, 2018
Remi A, Nout, Melanie E, Powell, Stephanie M, de Boer, Carien L, Creutzberg   +3 more
openaire   +2 more sources

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Lancet Oncology, The, 2017
Kevin J Harrington, Robert L Ferris, Lisa F Licitra   +2 more
exaly  

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Lancet Oncology, The, 2015
Antoni Ribas, Igor Puzanov, Reinhard Dummer   +2 more
exaly  

PERSONAL INVESTIGATION / PERSONAL INVESTIGATION

2022
openaire   +1 more source